NPI: 1679718225 · ORANGE, CA 92868 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 12/11/2008
Authorized official WEY, SAMUEL controls 20+ related entities in our dataset. Read more
| Authorized Official | WEY, SAMUEL (VP LICENSURE & CERTIFICATION) |
| NPI Enumeration Date | 12/11/2008 |
Other providers sharing the same authorized official: WEY, SAMUEL
| Provider | City | State | Total Paid |
|---|---|---|---|
| DVA HEALTHCARE RENAL CARE INC | NORTH HOLLYWOOD | CA | $16.47M |
| DVA HEALTHCARE RENAL CARE INC | DELANO | CA | $16.43M |
| DVA RENAL HEALTHCARE INC | LOS ANGELES | CA | $15.51M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $14.93M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.67M |
| DVA RENAL HEALTHCARE INC | OAKLAND | CA | $13.42M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.25M |
| DVA HEALTHCARE RENAL CARE INC | YUMA | AZ | $12.88M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $12.77M |
| DVA RENAL HEALTHCARE INC | FULLERTON | CA | $12.19M |
| DVA HEALTHCARE RENAL CARE INC | POMONA | CA | $11.96M |
| DVA RENAL HEALTHCARE INC | ANAHEIM | CA | $11.32M |
| DVA RENAL HEALTHCARE INC | ESCONDIDO | CA | $10.94M |
| DVA HEALTHCARE RENAL CARE INC | COSTA MESA | CA | $10.08M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $9.46M |
| DVA RENAL HEALTHCARE INC | VISALIA | CA | $9.22M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $8.83M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $8.56M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $7.78M |
| DVA RENAL HEALTHCARE INC | PALM SPRINGS | CA | $7.48M |
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 37,842 | $2.87M |
| 2019 | 43,442 | $2.74M |
| 2020 | 55,369 | $2.81M |
| 2021 | 56,613 | $2.79M |
| 2022 | 43,199 | $2.61M |
| 2023 | 23,465 | $3.47M |
| 2024 | 11,911 | $2.56M |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 90999 | Unlisted dialysis procedure, inpatient or outpatient | 110,157 | 8,168 | $17.71M |
| A4657 | Syringe, with or without needle, each | 3,312 | 2,089 | $883K |
| J0887 | Injection, epoetin beta, 1 microgram, (for esrd on dialysis) | 2,812 | 1,476 | $326K |
| 90945 | 2,483 | 98 | $312K | |
| 0250 | 5,943 | 881 | $207K | |
| J1270 | Injection, doxercalciferol, 1 mcg | 48,247 | 4,029 | $198K |
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 65,387 | 5,489 | $75K |
| J1756 | Injection, iron sucrose, 1 mg | 16,991 | 5,114 | $61K |
| 82728 | 1,638 | 1,467 | $53K | |
| 90674 | 343 | 332 | $8K | |
| 90677 | 17 | 13 | $3K | |
| 90662 | 69 | 67 | $3K | |
| J0604 | Cinacalcet, oral, 1 mg, (for esrd on dialysis) | 1,103 | 242 | $2K |
| 83970 | 1,782 | 1,570 | $2K | |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 584 | 411 | $1K |
| 90661 | 41 | 41 | $1K | |
| 90747 | 18 | 15 | $1K | |
| 85041 | 2,027 | 1,789 | $735.41 | |
| 82108 | 156 | 141 | $404.86 | |
| 83550 | 1,652 | 1,447 | $122.23 | |
| 83540 | 1,713 | 1,504 | $93.00 | |
| G0008 | Administration of influenza virus vaccine | 99 | 92 | $51.56 |
| 85048 | 2,015 | 1,779 | $36.21 | |
| 0305 | 109 | 45 | $0.00 | |
| 0636 | 1,195 | 86 | $0.00 | |
| 0270 | 76 | 45 | $0.00 | |
| 0301 | 196 | 43 | $0.00 | |
| 0821 | 151 | 133 | $0.00 | |
| 0634 | 1,525 | 100 | $0.00 |